ETON — Eton Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.43bn
- $1.43bn
- $79.95m
Eton Pharma falls after fourth-quarter loss
Eton Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Eton Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview
Eton Pharma rises on study results for rare disease drug
Brief: Eton Pharmaceuticals Acquires Galzin
Brief: Eton Pharmaceuticals Closes Acquisition Of Increlex® (Mecasermin Injection)
Brief: Eton Pharmaceuticals Announces Final Readout Of Pku Golike® Clinical Trial
Brief: Eton Pharmaceuticals Announces Acquisition Of U.S. Rights To Amglidia
Eton Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Eton Pharmaceuticals Q3 Net Income USD 627 Thousand
Eton Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview
Eton Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Eton Pharmaceuticals Q2 Net Income USD -3.041 Million
Eton Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400
Eton Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Eton Pharmaceuticals Q1 Net Income USD -811 Thousand
Eton Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Eton Pharmaceuticals Enters Into Agreement To Issue & Sell 1.3 Mln Shares Of Common Stock At Price Of $3.50 Per Share